{"Autism": [0, 179, 186], "spectrum": [1], "disorder": [2, 22, 316], "(ASD),": [3], "characterized": [4], "by": [5], "deficits": [6], "in": [7, 30, 56, 61, 65, 73, 105, 126, 251, 259, 342, 360], "social": [8, 263], "communication": [9, 264], "and": [10, 33, 45, 80, 83, 101, 128, 151, 162, 171, 184, 196, 198, 202, 230, 262, 290, 295, 345, 355], "the": [11, 31, 43, 57, 91, 137, 159, 168, 178, 185, 244, 361], "presence": [12], "of": [13, 36, 47, 51, 78, 93, 103, 111, 124, 130, 139, 149, 158, 194, 200, 216, 300, 320, 350, 358, 366], "restricted,": [14], "repetitive": [15], "behaviors": [16, 172], "or": [17, 121, 255, 286, 376, 385], "interests,": [18], "is": [19, 68, 141, 152, 276], "a": [20, 106, 142, 146, 304, 324], "neurodevelopmental": [21], "affecting": [23], "approximately": [24, 34, 348, 356], "2.3%": [25, 64, 349], "children": [26, 252, 351], "aged": [27, 352], "8": [28, 353], "years": [29, 110, 254, 354], "US": [32], "2.2%": [35, 357], "adults.": [37], "This": [38], "review": [39], "summarizes": [40], "evidence": [41], "on": [42, 154, 167, 271], "diagnosis": [44, 92, 138], "treatment": [46], "ASD.The": [48], "estimated": [49], "prevalence": [50], "ASD": [52, 94, 104, 140, 212], "has": [53], "been": [54, 96], "increasing": [55], "US,": [58], "from": [59], "1.1%": [60], "2008": [62], "to": [63, 90, 116, 266], "2018,": [66], "which": [67], "likely": [69], "associated": [70, 334], "with": [71, 145, 206, 211, 233, 303, 309, 323, 329, 335, 381], "changes": [72, 341], "diagnostic": [74, 81, 190], "criteria,": [75], "improved": [76], "performance": [77], "screening": [79], "tools,": [82], "increased": [84], "public": [85], "awareness.": [86], "No": [87], "biomarkers": [88], "specific": [89, 382], "have": [95, 192, 213], "identified.": [97], "Common": [98], "early": [99], "signs": [100], "symptoms": [102], "child's": [107, 160], "first": [108], "2": [109], "life": [112], "include": [113], "no": [114, 120], "response": [115], "name": [117], "when": [118], "called,": [119], "limited": [122], "use": [123], "gestures": [125], "communication,": [127], "lack": [129], "imaginative": [131], "play.": [132], "The": [133], "criterion": [134], "standard": [135], "for": [136, 257, 278, 314], "comprehensive": [143], "evaluation": [144], "multidisciplinary": [147], "team": [148], "clinicians": [150], "based": [153, 270], "semistructured": [155, 163], "direct": [156], "observation": [157], "behavior": [161], "caregiver": [164], "interview": [165], "focused": [166], "individual's": [169], "development": [170], "using": [173], "standardized": [174, 272], "measures,": [175], "such": [176, 242, 282, 373], "as": [177, 243, 283, 374], "Diagnostic": [180, 187], "Observation": [181], "Schedule-Second": [182], "Edition": [183], "Interview.": [188], "These": [189, 331], "measures": [191], "sensitivity": [193], "91%": [195], "80%": [197], "specificity": [199], "76%": [201], "72%,": [203], "respectively.": [204], "Compared": [205], "people": [207], "without": [208], "ASD,": [209], "individuals": [210], "higher": [214], "rates": [215], "depression": [217], "(20%": [218], "vs": [219, 223, 228, 237], "7%),": [220], "anxiety": [221, 375], "(11%": [222], "5%),": [224, 229], "sleep": [225], "difficulties": [226], "(13%": [227], "epilepsy": [231], "(21%": [232], "co-occurring": [234, 279, 370], "intellectual": [235], "disability": [236], "0.8%).": [238], "Intensive": [239], "behavioral": [240, 367, 383], "interventions,": [241, 368], "Early": [245], "Start": [246], "Denver": [247], "Model,": [248], "are": [249, 312, 333], "beneficial": [250], "5": [253], "younger": [256], "improvement": [258], "language,": [260], "play,": [261], "(small": [265], "medium": [267], "effect": [268, 306, 326], "size": [269], "mean": [273, 298, 318], "difference).": [274], "Pharmacotherapy": [275], "indicated": [277], "psychiatric": [280, 371], "conditions,": [281, 372], "emotion": [284], "dysregulation": [285], "attention-deficit/hyperactivity": [287, 315], "disorder.": [288], "Risperidone": [289], "aripiprazole": [291], "can": [292], "improve": [293], "irritability": [294], "aggression": [296], "(standardized": [297, 317], "difference": [299, 319], "1.1,": [301], "consistent": [302, 322], "large": [305], "size)": [307, 327], "compared": [308, 328], "placebo.": [310, 330], "Psychostimulants": [311], "effective": [313], "0.6,": [321], "moderate": [325], "medications": [332], "adverse": [336], "effects": [337], "including,": [338], "most": [339], "commonly,": [340], "appetite,": [343], "weight,": [344], "sleep.ASD": [346], "affects": [347], "adults": [359], "US.": [362], "First-line": [363], "therapy": [364, 384], "consists": [365], "while": [369], "aggression,": [377], "may": [378], "be": [379], "treated": [380], "medication.": [386]}